National Notifiable Diseases Surveillance System, 1 April to 30 June 2015

The National Notifiable Diseases Surveillance System collates data from Australian states and territories. These data have been published on the Department of Health website and quarterly data are published in Communicable Diseases Intelligence. This page contains data for the reporting period 1 April to 30 June 2015.

Page last updated: 16 October 2015

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 58,031 notifications to the National Notifiable Diseases Surveillance System (NNDSS) with a notification received date between 1 April to 30 June 2015 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Table 1: Reporting of notifiable diseases by jurisdiction
Disease Data received from:
* Infection with Shiga toxin/verotoxin-producing Escherichia coli.

NEC Not elsewhere classified.
Bloodborne diseases
Hepatitis (NEC)
 All jurisdictions
Hepatitis B (newly acquired)
 All jurisdictions
Hepatitis B (unspecified)
 All jurisdictions
Hepatitis C (newly acquired)
 All jurisdictions except Queensland
Hepatitis C (unspecified)
 All jurisdictions
Hepatitis D
 All jurisdictions
Gastrointestinal diseases
Botulism
 All jurisdictions
Campylobacteriosis
 All jurisdictions except New South Wales
Cryptosporidiosis
 All jurisdictions
Haemolytic uraemic syndrome
 All jurisdictions
Hepatitis A
 All jurisdictions
Hepatitis E
 All jurisdictions
Listeriosis
 All jurisdictions
STEC, VTEC*
 All jurisdictions
Salmonellosis
 All jurisdictions
Shigellosis
 All jurisdictions
Typhoid fever
 All jurisdictions
Quarantinable diseases
Cholera
 All jurisdictions
Highly pathogenic avian influenza (human)
 All jurisdictions
Plague
 All jurisdictions
Rabies
 All jurisdictions
Severe acute respiratory syndrome
 All jurisdictions
Smallpox
 All jurisdictions
Viral haemorrhagic fever
 All jurisdictions
Yellow fever
 All jurisdictions
Sexually transmissible infections
Chlamydia
 All jurisdictions
Donovanosis
 All jurisdictions
Gonococcal infection
 All jurisdictions
Syphilis - congenital
 All jurisdictions
Syphilis <2 years duration
 All jurisdictions
Syphilis >2 years or unspecified duration
 All jurisdictions
Vaccine preventable diseases
Diphtheria
 All jurisdictions
Haemophilus influenzae type b
 All jurisdictions
Influenza (laboratory confirmed)
 All jurisdictions
Measles
 All jurisdictions
Mumps
 All jurisdictions
Pertussis
 All jurisdictions
Pneumococcal disease – invasive
 All jurisdictions
Poliovirus infection
 All jurisdictions
Rubella
 All jurisdictions
Rubella – congenital
 All jurisdictions
Tetanus
 All jurisdictions
Varicella zoster (chickenpox)
 All jurisdictions except New South Wales
Varicella zoster (shingles)
 All jurisdictions except New South Wales
Varicella zoster (unspecified)
 All jurisdictions except New South Wales
Vectorborne diseases
Barmah Forest virus infection
 All jurisdictions
Chikungunya virus infection
 All jurisdictions
Dengue virus infection
 All jurisdictions
Flavivirus infection (unspecified)
 All jurisdictions
Japanese encephalitis virus infection
 All jurisdictions
Kunjin virus infection
 All jurisdictions
Malaria
 All jurisdictions
Murray Valley encephalitis virus infection
 All jurisdictions
Ross River virus infection
 All jurisdictions
Zoonoses
Anthrax
 All jurisdictions
Australian bat lyssavirus infection
 All jurisdictions
Brucellosis
 All jurisdictions
Leptospirosis
 All jurisdictions
Lyssavirus infection (NEC)
 All jurisdictions
Ornithosis
 All jurisdictions
Q fever
 All jurisdictions
Tularaemia
 All jurisdictions
Other bacterial infections
Legionellosis
 All jurisdictions
Leprosy
 All jurisdictions
Meningococcal infection – invasive
 All jurisdictions
Tuberculosis
 All jurisdictions

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 April to 30 June 2015, by date of diagnosis*
  State or territory Total 2nd quarter 2015 Total 1st quarter 2015 Total 2nd quarter 2014 Last 5 years mean 2nd quarter Ratio Year to date 2015 Last 5 years YTD mean
Disease ACT NSW NT Qld SA Tas. Vic. WA
* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis   unspecified.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

§ Infection with Shiga toxin/verotoxin-producing Escherichia coli.

|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

¶ The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

** In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

†† Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.
Bloodborne diseases
Hepatitis (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Hepatitis B (newly acquired)†
0
9
0
11
3
1
7
8
39
40
45
45.6
0.9
79
101.6
Hepatitis B (unspecified)‡
22
536
35
263
91
11
423
142
1,523
1,612
1,620
1,628.8
0.9
3,122
3,256.0
Hepatitis C (newly acquired)†
4
4
0
0
11
9
32
45
105
104
135
111.4
0.9
209
223.4
Hepatitis C (unspecified)‡
31
815
41
633
114
57
544
237
2,472
2,618
2,570
2,522.0
1.0
5,072
5,033.6
Hepatitis D
0
3
0
3
3
0
2
0
11
11
17
12.4
0.9
22
23.6
Gastrointestinal diseases
Botulism
0
0
0
0
0
0
0
0
0
1
1
0.6
0.0
1
1.0
Campylobacteriosis
129
NN
85
1,616
412
198
915
652
4,007
5,562
4,663
3,701.4
1.1
9,509
8,141.8
Cryptosporidiosis
6
210
34
351
124
3
175
58
961
1,507
664
715.4
1.3
2,464
1,755.0
Haemolytic uraemic syndrome
0
4
0
0
0
0
0
0
4
4
5
3.0
1.3
8
8.6
Hepatitis A
1
10
0
2
2
1
9
3
28
88
41
40.4
0.7
116
109.2
Hepatitis E
0
2
0
0
0
0
1
0
3
10
24
11.4
0.3
13
24.4
Listeriosis
0
7
1
2
1
0
7
0
18
16
20
18.2
1.0
34
44.0
STEC, VTEC§
0
2
0
11
17
0
3
0
33
27
33
22.4
1.5
60
56.4
Salmonellosis
32
887
170
1,322
354
42
927
386
4,120
6,524
4,216
3,032.6
1.4
10,587
7,448.2
Shigellosis
0
32
28
47
18
0
109
21
255
339
209
133.2
1.9
592
326.2
Typhoid fever
1
12
0
2
2
0
9
3
29
43
22
25.0
1.2
72
76.6
Quarantinable diseases
Cholera
0
0
0
0
1
0
0
0
1
0
1
2.0
0.5
1
2.4
Highly pathogenic avian influenza (human)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Plague
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rabies
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Severe acute respiratory syndrome
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Smallpox
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Viral haemorrhagic fever
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Yellow fever
0
0
0
0
0
0
0
0
0
0
0
0.5
0.0
0
0.5
Sexually transmissible infections
Chlamydia||,¶
333
5,416
665
5,115
1,311
411
8
2,782
16,041
22,407
22,149
20,514.4
0.8
38,337
41,818.0
Donovanosis
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.2
Gonococcal infection
42
1,259
450
744
244
13
1,255
523
4,530
4,700
4,010
3,415.2
1.3
9,212
6,855.4
Syphilis – congenital
0
0
1
1
0
0
0
0
2
0
0
0.8
2.5
2
2.0
Syphilis < 2 years duration
3
152
51
123
10
4
213
34
590
603
503
379.8
1.6
1,189
763.6
Syphilis > 2 years or unspecified duration‡,¶
3
143
26
66
25
4
184
8
459
488
470
394.6
1.2
947
761.8
Vaccine preventable diseases
Diphtheria
0
0
0
0
0
0
0
0
0
1
0
0.8
0.0
1
1.0
Haemophilus influenzae type b
0
3
0
1
0
0
0
0
4
2
6
5.4
0.7
6
8.2
Influenza (laboratory confirmed)
129
1,848
46
2,534
1,996
133
1,882
1,128
9,696
4,600
4,592
3,870.8
2.5
14,259
5,982.8
Measles
1
3
0
3
0
0
9
3
19
27
72
33.4
0.6
46
90.8
Mumps
0
14
0
13
8
4
2
56
97
62
40
47.2
2.1
157
93.4
Pertussis
136
2,019
10
333
262
8
1,002
320
4,090
4,116
2,116
4,699.2
0.9
8,166
10,611.6
Pneumococcal disease – invasive
5
132
19
65
33
10
89
43
396
191
407
464.4
0.9
586
684.0
Poliovirus infection
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Rubella
1
2
0
0
2
0
0
0
5
5
3
8.8
0.6
10
20.4
Rubella – congenital
0
0
0
0
0
0
0
0
0
0
0
0.2
0.0
0
0.2
Tetanus
0
1
0
0
0
0
0
0
1
0
0
0.6
1.7
1
2.0
Varicella zoster (chickenpox)
27
NN
23
79
76
9
201
113
528
533
488
434.4
1.2
1,058
823.2
Varicella zoster (shingles)
44
NN
80
14
629
44
366
350
1,527
1,612
1,357
1,077.8
1.4
3,126
2,178.2
Varicella zoster (unspecified)
26
NN
1
1,581
37
41
1,190
340
3,216
3,133
2,827
2,307.2
1.4
6,318
4,671.2
Vectorborne diseases
Barmah Forest virus infection
0
69
5
94
0
0
3
15
186
271
217
578.4
0.3
456
1,278.2
Chikungunya virus infection
0
5
2
8
1
0
8
2
26
56
22
17.4
1.5
82
35.6
Dengue virus infection
0
61
22
58
22
7
52
154
376
742
522
367.8
1.0
1,110
842.8
Flavivirus infection (unspecified)
0
0
0
1
1
0
0
0
2
4
8
3.6
0.6
6
8.4
Japanese encephalitis virus infection
0
0
0
0
0
0
0
0
0
2
0
0.4
0.0
2
0.6
Kunjin virus infection**
0
0
0
0
0
0
0
0
0
0
1
0.6
0.0
0
0.8
Malaria
1
8
1
15
0
1
10
11
47
64
85
86.0
0.5
110
190.4
Murray Valley encephalitis virus infection**
0
0
1
0
0
0
0
0
1
1
0
1.4
0.7
2
3.2
Ross River virus infection
3
423
62
1,087
27
2
88
305
1,997
5,745
1,306
1,337.4
1.5
7,723
3,325.0
Zoonoses
Anthrax
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.2
Australian bat lyssavirus infection
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.2
Brucellosis
0
4
0
1
0
0
0
0
5
4
3
4.6
1.1
9
11.4
Leptospirosis
0
2
1
12
0
0
2
0
17
23
32
41.0
0.4
40
87.0
Lyssavirus infection (NEC)
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.0
Ornithosis
0
0
0
0
1
0
1
0
2
1
6
12.6
0.2
3
25.4
Q fever
0
47
1
63
2
0
11
3
127
153
119
103.8
1.2
279
205.2
Tularaemia
0
0
0
0
0
0
0
0
0
0
0
0.0
0.0
0
0.3
Other bacterial infections
Legionellosis
0
27
3
24
3
2
22
17
98
95
112
100.6
1.0
192
186.8
Leprosy
0
1
0
0
0
0
1
0
2
1
4
3.4
0.6
3
4.8
Meningococcal infection – invasive††
0
13
1
8
7
0
15
3
47
29
41
49.4
1.0
74
89.4
Tuberculosis
5
117
11
45
6
3
70
31
288
285
301
290.6
1.0
569
608.4
Total
985
14,302
1,876
16,351
5,856
1,018
9,847
7,796
58,031
68,462
56,105
126,042

Top of page

Table 3: Notification rates of diseases, 1 April to 30 June 2015, by state or territory. (Annualised rate per 100,000 population)*,†
Disease State or territory Aust.
ACT NSW NT Qld SA Tas. Vic. WA
* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Rate per 100,000 of population. Annualisation Factor was 4.0

‡ Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis C unspecified.

§ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

|| Infection with Shiga toxin/verotoxin-producing Escherichia coli.

¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens. From 1 July 2013 case definition changed to exclude all ocular infections.

** The national case definitions for chlamydial, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

†† In the Australian Capital Territory, Murray Valley encephalitis virus infection and Kunjin virus infection are combined under Murray Valley encephalitis virus infection.

‡‡ Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.
Bloodborne diseases
Hepatitis (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Hepatitis B (newly acquired)‡
0.0
0.5
0.0
0.9
0.7
0.8
0.5
1.2
0.7
Hepatitis B (unspecified)§
22.8
28.5
57.2
22.3
21.6
8.5
29.0
22.1
26.0
Hepatitis C (newly acquired)‡
4.2
0.2
0.0
0.0
2.6
7.0
2.2
7.0
1.8
Hepatitis C (unspecified)§
32.2
43.4
67.0
53.6
27.1
44.3
37.3
37.0
42.1
Hepatitis D
0.0
0.2
0.0
0.3
0.7
0.0
0.1
0.0
0.2
Gastrointestinal diseases
Botulism
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Campylobacteriosis
133.9
NN
139.0
136.9
97.8
153.9
62.7
101.7
100.4
Cryptosporidiosis
6.2
11.2
55.6
29.7
29.4
2.3
12.0
9.0
16.4
Haemolytic uraemic syndrome
0.0
0.2
0.0
0.0
0.0
0.0
0.0
0.0
0.1
Hepatitis A
1.0
0.5
0.0
0.2
0.5
0.8
0.6
0.5
0.5
Hepatitis E
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.1
Listeriosis
0.0
0.4
1.6
0.2
0.2
0.0
0.5
0.0
0.3
STEC, VTEC||
0.0
0.1
0.0
0.9
4.0
0.0
0.2
0.0
0.6
Salmonellosis
33.2
47.2
278.0
112.0
84.0
32.6
63.5
60.2
70.2
Shigellosis
0.0
1.7
45.8
4.0
4.3
0.0
7.5
3.3
4.3
Typhoid fever
1.0
0.6
0.0
0.2
0.5
0.0
0.6
0.5
0.5
Quarantinable diseases
Cholera
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.0
0.0
Human pathogenic avian influenza (human)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Plague
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rabies
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Severe acute respiratory syndrome
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Smallpox
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Viral haemorrhagic fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Yellow fever
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Sexually transmitted infections
Chlamydia¶,**
345.5
288.2
1,087.4
433.4
311.1
319.4
0.5
433.8
273.3
Donovanosis
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Gonococcal infection**
43.6
67.0
735.9
63.0
57.9
10.1
86.0
81.5
77.2
Syphilis – congenital
0.0
0.0
1.6
0.1
0.0
0.0
0.0
0.0
0.0
Syphilis < 2 years duration**
3.1
8.1
83.4
10.4
2.4
3.1
14.6
5.3
10.1
Syphilis > 2 years or unspecified duration§,**
3.1
7.6
42.5
5.6
5.9
3.1
12.6
1.2
7.8
Vaccine preventable diseases
Diphtheria
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Haemophilus influenzae type b
0.0
0.2
0.0
0.1
0.0
0.0
0.0
0.0
0.1
Influenza (laboratory confirmed)
133.9
98.4
75.2
214.7
473.7
103.4
128.9
175.9
165.2
Measles
1.0
0.2
0.0
0.3
0.0
0.0
0.6
0.5
0.3
Mumps
0.0
0.7
0.0
1.1
1.9
3.1
0.1
8.7
1.7
Pertussis
141.1
107.5
16.4
28.2
62.2
6.2
68.6
49.9
69.7
Pneumococcal disease – invasive
5.2
7.0
31.1
5.5
7.8
7.8
6.1
6.7
6.7
Poliovirus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Rubella
1.0
0.1
0.0
0.0
0.5
0.0
0.0
0.0
0.1
Rubella – congenital
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Tetanus
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Varicella zoster (chickenpox)
28.0
NN
37.6
6.7
18.0
7.0
13.8
17.6
13.2
Varicella zoster (shingles)
45.7
NN
130.8
1.2
149.3
34.2
25.1
54.6
38.3
Varicella zoster (unspecified)
27.0
NN
1.6
133.9
8.8
31.9
81.5
53.0
80.6
Vectorborne diseases
Barmah Forest virus infection
0.0
3.7
8.2
8.0
0.0
0.0
0.2
2.3
3.2
Chikungunya virus infection
0.0
0.3
3.3
0.7
0.2
0.0
0.5
0.3
0.4
Dengue virus infection
0.0
3.2
36.0
4.9
5.2
5.4
3.6
24.0
6.4
Flavivirus infection (unspecified)
0.0
0.0
0.0
0.1
0.2
0.0
0.0
0.0
0.0
Japanese encephalitis virus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Kunjin virus infection††
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Malaria
1.0
0.4
1.6
1.3
0.0
0.8
0.7
1.7
0.8
Murray Valley encephalitis virus infection††
0.0
0.0
1.6
0.0
0.0
0.0
0.0
0.0
0.0
Ross River virus infection
3.1
22.5
101.4
92.1
6.4
1.6
6.0
47.6
34.0
Zoonoses
Anthrax
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Australia bat lyssavirus infection
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Brucellosis
0.0
0.2
0.0
0.1
0.0
0.0
0.0
0.0
0.1
Leptospirosis
0.0
0.1
1.6
1.0
0.0
0.0
0.1
0.0
0.3
Lyssavirus infection (NEC)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Ornithosis
0.0
0.0
0.0
0.0
0.2
0.0
0.1
0.0
0.0
Q fever
0.0
2.5
1.6
5.3
0.5
0.0
0.8
0.5
2.2
Tularaemia
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Other bacterial diseases
Legionellosis
0.0
1.4
4.9
2.0
0.7
1.6
1.5
2.7
1.7
Leprosy
0.0
0.1
0.0
0.0
0.0
0.0
0.1
0.0
0.0
Meningococcal infection – invasive‡‡
0.0
0.7
1.6
0.7
1.7
0.0
1.0
0.5
0.8
Tuberculosis
5.2
6.2
18.0
3.8
1.4
2.3
4.8
4.8
4.9

Top of page

In this section

CDI Search

Search Communicable Diseases Intelligence

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now

Communicable Diseases Surveillance